TRAF4 and prostate carcinoma: In tumors, gene amplification represents the most frequently observed genetic alteration involving TRAF4.[33] Additionally, TRAF4 shows abnormally elevated expression levels in 43% of tumor tissues across various known types of human cancers,[34, 35, 36, 37] encompassing breast cancer, endometrial cancer, and prostate cancer.